About Us

Archives






Akero Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Update

Posted: August 15, 2021 at 1:51 am


SOUTH SAN FRANCISCO, Calif., Aug. 13, 2021 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a cardio-metabolic biotechnology company developing transformational treatments for non-alcoholic steatohepatitis (NASH), today reported second quarter financial results for the period ending June 30, 2021.

Read more from the original source:
Akero Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Update

Related Post

No Comments

No comments yet.

Sorry, the comment form is closed at this time.